logo
Plus   Neg
Share
Email

Stock Alert: Nike Inc.

Nike Inc. (NKE), one of the largest retailer of sports apparel in the world, has witnessed nearly 17% drop in stock price since January, largely due to the ongoing coronavirus crisis.

The ongoing COVID-19 pandemic has brought severe damage to the sports apparel industry. All major retailers have been forced to close their stores across the globe, especially in Europe and the U.S., one of the key markets for these apparel companies.

Cancellation of all major sporting events including the football and basketball leagues, Olympics, Euro Cup 2020 are expected to make significant dent on the top line of sports apparel makers.

Shares of Nike closed Monday's trading at $84.46, down $2.33 or 2.68%. The stock has been trading in the range of $105.62 - $60.58 in the year-to-date period. NKE is currently trading at $84.63, up $0.17 or 0.20% in after-market hours.

Nike has more than 1,100 branded stores globally and almost all of the company's growth last year came from direct to consumer sales at its retail stores, factory outlets and Nike.com.

The company has closed all of its stores in the U.S., Canada, Western Europe, Australia and New Zealand. However, China, which is Nike's most profitable geographical segment, has almost fully recovered from coronavirus pandemic. This could help the company to generate sales in the coming quarter.

Nike will be releasing its full-year results in June, with Wall Street analysts estimating earnings of $2.26 per share on revenue of $39.08 billion. Nike last year reported earnings of $2.49 per share on revenues of $39.12 billion.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, said that the current state of the COVID-19 pandemic in the U.S. is "really not good." The U.S. is the country worst-affected by the coronavirus and has recently seen a surge in coronavirus infections as lockdown restrictions are eased. Granules Pharmaceuticals, Inc. recalled twelve (12) lots of type 2 diabetes medication Metformin hydrochloride Extended-Release, in the form of oral film-coated tablets, for the potential presence of nitrosamine impurity, N-Nitrosodimethylamine (NDMA), above levels of the Acceptable Daily Intake Limit (ADI), the U.S. Food and Drug Administration or FDA said in a statement. Palantir Technologies Inc., the Silicon Valley big data analytics company that has handled U.S. government's certain sensitive projects, said it has confidentially filed documents with the Securities and Exchange Commission to go public. In a statement, the company said the proposed public listing of its Class A common stock is expected to take place after the SEC completes its review process.
Follow RTT